Login / Signup

Immunosuppression after pediatric liver transplant: The parents' perspective.

Irini D BatsisJohn BucuvalasElizabeth EisenbergJennifer LauJames E SquiresSandy FengEmily R Perito
Published in: Clinical transplantation (2023)
Children of respondents (n = 82) were a median 4 years from primary LT (range 0-22); 73% were on immunosuppression monotherapy. Parents' top concerns were related to immunosuppression complications; 46% were more concerned about immunosuppression complications than rejection; only 17% were more concerned about rejection than immunosuppression complications. Among parents of children on immunosuppression monotherapy, 29% still worried more about immunosuppression complications than rejection, 48% expressed equal concern for both. Time since LT (0-4 vs >4 years) was not associated with concern level for rejection or immunosuppression complications. Caregivers were significantly more certain that their child's immunosuppression regimen was correct to prevent rejection than to mitigate complications (p<0.005). This article is protected by copyright. All rights reserved.
Keyphrases
  • risk factors
  • young adults
  • mental health
  • randomized controlled trial
  • palliative care
  • open label
  • study protocol